Zoledronic acid in nine patients with transient osteoporosis of the hip

[1]  M. Kechagia,et al.  Zoledronic acid is effective and safe in migratory osteoporosis. , 2019, Rheumatology.

[2]  R. Wermers,et al.  TRANSIENT OSTEOPOROSIS: CLINICAL SPECTRUM IN ADULTS AND ASSOCIATED RISK FACTORS. , 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[3]  L. Greene,et al.  Transient osteoporosis of the hip: review of the literature , 2017, Osteoporosis International.

[4]  R. Blanco,et al.  Zoledronic Acid Treatment in Primary Bone Marrow Edema Syndrome , 2017, Journal of pain & palliative care pharmacotherapy.

[5]  A. Goldberg,et al.  Bone Marrow Edema Syndrome of the Foot and Ankle , 2016, Foot & ankle specialist.

[6]  C. Trevisan,et al.  Risk factors in transient osteoporosis: a retrospective study on 23 cases , 2016, Clinical Rheumatology.

[7]  Sanjeev Patel.  Primary bone marrow oedema syndromes. , 2014, Rheumatology.

[8]  J. Rasker,et al.  Transient osteoporosis of the hip, complete resolution after treatment with alendronate as observed by MRI description of eight cases and review of the literature , 2012, Clinical Rheumatology.

[9]  T. Arayssi,et al.  Oral bisphosphonates in treatment of transient osteoporosis , 2008, Clinical Rheumatology.

[10]  M. Varenna,et al.  Intravenous pamidronate in the treatment of transient osteoporosis of the hip. , 2002, Bone.